More consideration needs to be given to depressive symptoms as both a risk factor and a complication of stroke, says a neurologist.
Similarities in insulin signaling mechanisms between the brains of Alzheimer’s disease patients and the pancreas of diabetic patients may point the way to improved treatment for the former, according to researchers.
Traditionally, hospital buildings are constructed first and the infrastructures fitted into them later. Ideally, for maximum efficiency, it should be the other way around, says a surgeon.
The humanized anti-CD20 monoclonal antibody, ocrelizumab, reduced the relapse rate and slowed disability progression in individuals with relapsing multiple sclerosis (MS), according to results of the OPERA I and OPERA II* trials.
Ocrelizumab, a humanized anti-CD20 monoclonal antibody, was associated with a reduced rate of disability progression in individuals with primary progressive multiple sclerosis (MS), based on findings of the phase III ORATORIO* trial.